ScoreWhy is PAVmed, Inc. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.59%
EBIT Growth (5y)
0.19%
EBIT to Interest (avg)
-60.79
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.18%
ROCE (avg)
0
ROE (avg)
30.98%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.36
EV to EBIT
-0.86
EV to EBITDA
-0.87
EV to Capital Employed
0.43
EV to Sales
17.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-50.31%
ROE (Latest)
-20.17%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET SALES(HY)
At USD 0.06 MM has Grown at 292.86%
OPERATING CASH FLOW(Y)
Highest at USD -7.73 MM
RAW MATERIAL COST(Y)
Fallen by -65.48% (YoY
EPS(Q)
Highest at USD -0.87
-17What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -3.55 MM has Fallen at -41.1%
NET PROFIT(Q)
At USD -2.34 MM has Fallen at -42.99%
ROCE(HY)
Lowest at -31.88%
DEBT-EQUITY RATIO
(HY)
Highest at 37.9 %
Here's what is working for PAVmed, Inc.
Net Sales
At USD 0.06 MM has Grown at 292.86%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Operating Cash Flow
Highest at USD -7.73 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
EPS
Highest at USD -0.87
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -65.48% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for PAVmed, Inc.
Pre-Tax Profit
At USD -3.55 MM has Fallen at -41.1%
over average net sales of the previous four periods of USD -2.52 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -2.34 MM has Fallen at -42.99%
over average net sales of the previous four periods of USD -1.64 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debt-Equity Ratio
Highest at 37.9 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
